BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4709209)

  • 1. Acute effects of 6-hydroxydopa on central monoaminergic neurons.
    Kostrzewa R; Jacobwitz D
    Eur J Pharmacol; 1973 Jan; 21(1):70-80. PubMed ID: 4709209
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain.
    Vrbanac JJ; Tilson HA; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1975; 3(1):57-64. PubMed ID: 1129355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional and biochemical effects of d-and 1-amphetamine on central catecholamine neurons.
    Svensson TH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(2):170-80. PubMed ID: 4257153
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 8. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 9. On the relationship between drug-induced changes in brain amines and body temperature.
    Ingenito AJ; Bonnycastle DD
    Can J Physiol Pharmacol; 1967 Jul; 45(4):723-32. PubMed ID: 5298528
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.
    Samanin R; Ghezzi D; Valzelli L; Garattini S
    Eur J Pharmacol; 1972 Sep; 19(3):318-22. PubMed ID: 4640855
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs.
    Nybäck H; Borzecki Z; Sedvall G
    Eur J Pharmacol; 1968 Nov; 4(4):395-403. PubMed ID: 5724916
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
    Schayer RW; Reilly MA
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of various drugs with amphetamine.
    Garattini S; Jori A; Samanin R
    Ann N Y Acad Sci; 1976; 281():409-25. PubMed ID: 798529
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
    Yehuda S; Wurtman RJ
    Nature; 1972 Dec; 240(5382):477-8. PubMed ID: 4565945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.